The Drug-Exposed Neonate and Neonatal Abstinence Syndrome: Risks, Identification and Therapies

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Video/Document(s)
Posttest
Evaluation
Starts On: 7/1/2019: 12:00 AM
Ends On: 6/30/2020: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 0.75
Description:

Faculty

Samuel F. Julian, MD
Assistant Professor, Pediatrics
Division of Newborn Medicine
Disclosures
Financial Relationships: Nothing to disclose

Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 44th Annual Symposium on Obstetrics & Gynecology, October 18-19, 2018, which was supported in part by The Foundation for Barnes-Jewish Hospital, Ferring Pharmaceutcals Inc., Medtronic and Cook Medical

Planning Committee

Crystal J. Carroll, RN, BSN, Nurse Coordinator
Financial Relationships: Nothing to disclose
Randall R. Odem, MD, Course Chair
Financial Relationships: Nothing to disclose
Antonina I. Frolova, MD, PhD, Clinical Fellow in Obstetrics and Gynecology
Financial Relationships: Nothing to disclose
Stephanie Jean Gunderson, MD, Clinical Fellow in Obstetrics and Gynecology
Financial Relationships: Nothing to disclose
Tammy S. Sonn, MD, Associate Professor of Obstetrics and Gynecology; Vice Chair, Education
Financial Relationships: Nothing to disclose

Objectives: The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
  • Recognize the prevalence of substances of abuse (SA) use across populations
  • Explain how maternal exposure to opioids leads to Neonatal Abstinence Syndrome (NAS)
  • Identify infants with opioid exposure and those with NAS
  • Implement therapies for NAS
Additional Information:
Target Audience: This course is planned and designed interprofessionally for physicians and nurses. This course is designed for practicing obstetricians and gynecologists, primary care physicians, as well as physicians in training, nurse practitioners, nurses and allied health professionals working within the area of OB/GYN.

Publication Date: July 1, 2019
Expiration Date: June 30, 2020

Accreditation Information:
wustlcme
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for this Activity:

Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 ANCC contact hours.

References:
  • THE COMMITTEE ON DRUGS, and THE COMMITTEE ON FETUS AND NEWBORN. Pediatrics 2012; 129:2 e540-e560
  • https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.htm
  • Villapiano NLG et al. "Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013." JAMA Pediatr. 2017
  • Grossman, MR et al. P. "A Novel Approach to Assessing Infants With Neonatal Abstinence Syndrome." Hospital Pediatrics, 2018.
Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.

Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.

Categories: Nurse, OBGYN, Pediatric


Powered By AI 4.5